Client Context
Our Client are a US-based biotech firm with global operations, sought to establish a research hub in Abu Dhabi, requiring regulatory approvals for sensitive biologics and animal imports, as well as expanding their sales and operation in the Middle East.
Challenge
Navigating stringent UAE regulations for cell-line approvals and biologics logistics while meeting aggressive launch timelines in the region.
ECG Intervention
- Secured government approvals for regulated cell-lines and R&D animals 60% faster than market averages.
- Designed a dedicated Kansas–Abu Dhabi logistics corridor, enabling biologics shipments in <48 hours.
- Provided compliance assurance with zero regulatory setbacks.
Impact
- Operations launched ahead of schedule, establishing Attentive as a regional biotech pioneer.
- Reduced time-to-market by 40% versus industry benchmarks.
- Strengthened UAE's positioning as a hub for advanced biotech research.
